Form 8-K - Current report:
SEC Accession No. 0001746473-25-000105
Filing Date
2025-06-09
Accepted
2025-06-09 17:29:38
Documents
14
Period of Report
2025-06-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plrx-20250605.htm   iXBRL 8-K 47050
2 EX-3.1 certificateofamendmenttoam.htm EX-3.1 10567
  Complete submission text file 0001746473-25-000105.txt   227472

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20250605.xsd EX-101.SCH 2914
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20250605_def.xml EX-101.DEF 16530
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20250605_lab.xml EX-101.LAB 29957
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20250605_pre.xml EX-101.PRE 17328
16 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20250605_htm.xml XML 4251
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 251035186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)